Plus save on the Signature Edition of the popular e-reader. Love reading or looking for the perfect gift for someone who does? Well, Amazon’s Kindle Paperwhite is seeing a solid discount this Cyber Monday. And Read more…
Daily Pivots: (S1) 138.49; (P) 139.04; (R1) 139.71; More… Breach of 137.66 support suggests that fall from 151.93 is resuming. Intraday bias in now on the downside for 100% projection of 146.78 to 137.66 from Read more…
Daily Pivots: (S1) 0.9422; (P) 0.9461; (R1) 0.9499; More… Intraday bias in USD/CHF remains neutral as consolidation from 0.9355 is still extending. On the downside, firm break of 0.9355 will resume the decline from 1.0146 Read more…
Daily Pivots: (S1) 1.2060; (P) 1.2094; (R1) 1.2129; More… Intraday bias in GBP/USD is turned neutral first as it continued to lose upside momentum with current retreat. Further rally is expected as long as 1.1777 Read more…
The social network has lost almost 67% of its 7,500 employees since the takeover of Elon Musk on October 27. Twitter is hiring. The social network lost in less than a month some 5,000 employees, Read more…
Daily Pivots: (S1) 1.0359; (P) 1.0394; (R1) 1.0433; More… EUR/USD’s breach of 1.0481 resistance indicates resumption of rise from 0.9534. Intraday bias is back on the upside. Further rally should be seen to 1.0609 fibonacci Read more…
Risk aversion is the theme of the day as protests in China spread to multiple cities. There might be talks that pressure is mounting on the government to exit zero-Covid policy early. Investors are clearly Read more…
The CEO of Tesla and Twitter is the richest man in the world. Elon Musk is visionary and controversial. He completely changed the way the world views the automobile, and forced one of the world’s Read more…
Stocks look set for a weaker opening Monday as investors react to rare public protests in China over the country’s strict Covid health policies. U.S. equity futures moved lower Monday as global investors reacted to Read more…
Science.org reported Sunday that a woman participating in the joint Bigoen-Eisai Clarity AD trial of an experimental Alzheimer’s treatment has died of a brain hemorrhage. Biogen (BIIB) – Get Free Report shares slumped lower Monday following Read more…